Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Response Genetics To Present New Data On Lung Cancer Supporting The Use Of Gene Expression To Help Personalize Cancer Therapy Selection
Response Genetics Inc. (Nasdaq: RGDX), a company focused on the development and sale of molecular diagnostic tests for cancer, will announce the results of separate analyses of KRAS gene mutations and TS and RRM1 gene expression in non-small cell lung cancer (NSCLC) during the 13th World Conference on Lung Cancer, which will be held July 31 to August 4. Results will provide insights into which patient subtypes are most likely to benefit from the commonly prescribed chemotherapies pemetrexed and gemcitabine.
generic viagra online
What Is Dyspraxia? How Is Dyspraxia Treated?
A person with dyspraxia has problems with movement and coordination. It is also known as "motor learning disability". Somebody with dyspraxia finds it hard to carry out smooth and coordinated movements. Dyspraxia often comes with language problems, and sometimes a degree of difficulty with perception and thought. Dyspraxia does not affect a person"s intelligence, but it can cause learning difficulties, especially for children.
News of the day
Sleep Difficulties May Occur With Parental Presence At Bedtime
Parental presence at bedtimes appears to have a greater negative impact on infant sleep than actual co-sleeping, according to a research abstract that will be presented on Wednesday, June 10, at SLEEP 2009, the 23rd Annual Meeting of the Associated Professional Sleep Societies.
Sexual Health

Cole Foundation Injects $2.5 Million To Bolster Leukemia Research

Canada has received new support to recruit some of its best minds in pediatric leukemia research, thanks to the Cole Foundation. The family foundation has generously pledged $2.5 million to support up-and-coming, Montreal-based researchers at the Universitçİ de Montrçİal, McGill University and the Universitçİ du Quçİbec"s Institut national de la recherche scientifique - Institut Armand-Frappier. The Cole Foundation investment will include: * Two Cole Foundation Mid-Career Grants totalling $620,000, allotted over four years, to permit the Universitçİ de Montrçİal and McGill University to hire one scientist each. * Three Cole Foundation Transition Awards, for a total of $225,000, to allow the Institut Armand-Frappier, the Universitçİ de Montrçİal and McGill University and their affiliated medical research institutes to hire a postdoctoral researcher each for tenure-track or associate professor positions. * Some $572,000 to create a pediatric leukemia cell bank based at the Sainte-Justine University Hospital Research Center. In addition, the Cole Foundation will contribute $637,000 to allow the Quebec Leukemia Cell Bank to expand its operation and preserve adolescent leukemia cells that will be widely available to researchers. Building on prior investments This new support builds on the Cole Foundation"s Fellowship Programme, which was created to encourage young researchers in search of a cure for pediatric leukemia and related diseases. This year, the Cole Foundation is injecting another $425,000 to propel the work of another 13 Cole Fellows. Since 2007, the Cole Foundation has generously funded some 31 post-doctoral and graduate research fellowships at the three institutions. "The faculties of medicine at the Universitçİ de Montrçİal and McGill University, along with the Institut Armand-Frappier, produce scientists who are at the forefront of the international battle against pediatric leukemia," said Barry Cole, president of the Cole Foundation. "These new investments, coupled with our ongoing Cole Fellowships, will serve as important tools to empower tomorrow"s scientists - right here in Montreal - so they may find new ways to conquer pediatric leukemia and related diseases." 2009 Cole Fellows Of the 13 new recipients announced for 2009, 10 will work at Universitçİ de Montrçİal-affiliated institutions such as the Institute for Research in Immunology Cancer (IRIC), Sainte-Justine University Hospital Research Center and Maisonneuve-Rosemont Hospital. At McGill, three Cole Fellows will work from the affiliated McGill University Health Centre and Lady Davis Research Centre of the Jewish General Hospital. The newly announced 2009 Cole Fellows are: * Marie-Claude Bourgeois-Daigneault, PhD program, UdeM * Marie Cargnello, PhD program, UdeM * ç‰tienne Caron, PhD program, UdeM * Cindy Degerny, post-PhD program, McGill * Neda Delgoshaie, PhD program, UdeM * Cyrus Khandanpour, post-PhD program, UdeM * John Mills, PhD program, McGill * Ali Mokdad, post-PhD program, UdeM * Elena Shirokova, post-PhD program, UdeM * Marie-Claude Sincennes, PhD program, UdeM * Urmila Tawar, post-PhD program, McGill * Cçİdric Tremblay, post-PhD program, UdeM * Brian Wilhelm, post-PhD program, UdeM Sylvain-Jacques Desjardins University of Montreal


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

İ Copyright 2009